title: dm3

status: Public on Jul 01 2014

city: Davis

first: Shajahan

last: Anver

address: 1002 LSA, One Shields Av

department: Plant Biology

institute: University of California Davis

description:
Δxap5Δpht1 double mutant strain haploid cells
Sample 13

data_processing:
All quality control steps were performed using the fastx_tool kit (http://hannonlab.cshl.edu/ fastx toolkit/index.html).
Reads were mapped to the complete S. pombe cDNA (EF2.12) and genomic DNA (from ftp.ensemblgenomes.org) using BWA (ver. 0.5.8c, Li and Durbin 2009, Bioinformatics 25(14): 1754-1760).
Differential expression analysis was performed using edgeR (Robinson et al. 2010)
Genome_build: Ensembl EF2.12 (ftp://ftp.ensemblgenomes.org/pub/fungi/release-12/fasta/schizosaccharomyces_pombe/cdna/Schizosaccharomyces_pombe.EF2.12.cdna.all.fa.gz)
Supplementary_files_format_and_content: Differential expression analyses  for sense transcripts, antisense transcripts, all annotated long terminal repeat (LTR) sequences and all intergenic region sequences in Δxap5, Δpht1 and Δxap5Δpht1

organism: Schizosaccharomyces pombe

source_name: delta-xap5 delta-pht1 double mutant strain haploid cells

growth_protocol: cells initially grown in YES medium at 30C overnight and these cultures were used to inoculate cultures in EMM50 at 37C. Exponentially growing cells at 37C in EMM50 were used for RNA extraction with three replicates per each genotype.

extract_protocol:
Cell lysis was performed as recommended by Sabatinos and Forsburg (2010, Yeast 23(3): 173-183) in 1 ml Trizol reagent (Invitrogen). RNA was extracted as per the Invitrogen Trizol reagent protocol. Extracted RNA was digested with DNase I (Qiagen) for 30 minutes at room temperature and cleaned up with 3M sodium acetate. rRNA was removed using the Ribo-Zero rRNA removal kit (human/mouse/rat, Epicentre) following the manufacturer’s protocol.
Strand specific cDNA libraries were made with random primers using a protocol by Wang et al. (2011, PloS one 6(10): e26426) after optimizations. Barcodes: WT1 - AACCG, WT2 - ACCAT, WT3 - GCTAT, WT4 - CATAT, xap5m1 - AGCTT, xap5m2 - CATTA, xap5m3 - CCTAG, pht1_1 - AATAG, pht1_2 - TAATG, pht1_3 - GGCTC, dm1 - ACCTA, dm2 - TTAGA, dm3 - GTATT
Samples were multiplexed and 100 bp single reads were sequenced in an Illumina Hi-seq sequencer (Hi-Seq 2000) in two lanes with an average sequence coverage of 11.8 million /library.

tag: strain background

tag: genotype/variation

value: delta-xap5 delta-pht1 double mutant; h-, ade6-M216, ura4-D18, leu1-32,  SPCC1020.12c::KanMx4, SPBC11B10.10c::NatMx4

value: exponentially growing haploid cells


title: 11-0027

status: Public on May 12 2015

type: RNA

city: Stanford

first: Timothy

middle: E

last: Sweeney

state: California

address: 1265 Welch Road, MSOB

department: Biomedical Informatics

country: USA

institute: Stanford University

description: gcRMA normalized

hyb_protocol: See original GSEs for clinical and technical information.

data_processing: All samples here were downloaded as .CEL files and re-normalized together using gcRMA using R package 'affy'.

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Whole Blood

tag: tissue

value: whole blood

tag: disease

value: Control


title: 15-0003

description: gcRMA normalized

scan_protocol: See original GSEs for clinical and technical information.


title: dm2

type: SRA

state: CA

description:
Δxap5Δpht1 double mutant strain haploid cells
Sample 12

library_source: transcriptomic


title: dm1

description:
Δxap5Δpht1 double mutant strain haploid cells
Sample 11


title: pht1_1

description:
Δpht1 mutant strain haploid cells
Sample 8

source_name: delta-pht1 mutant strain haploid cells

value: delta-pht1 mutant; h-, ade6-M216, ura4-D18, leu1-32,  SPBC11B10.10c::NatMx4


title: pht1_2

description:
Δpht1 mutant strain haploid cells
Sample 9


title: xap5m2

description:
Δxap5 mutant strain haploid cells
Sample 6

source_name: delta-xap5 mutant strain haploid cells

value: delta-xap5 mutant; (Bioneer-BG4186) h+, ade6-M216, ura4-D18, leu1-32, SPCC1020.12c::KanMx4


title: xap5m1

description:
Δxap5 mutant strain haploid cells
Sample 5


title: xap5m3

description:
Δxap5 mutant strain haploid cells
Sample 7


title: 15-0005

description: gcRMA normalized

label_protocol: See original GSEs for clinical and technical information.


title: Con006

status: Public on Aug 12 2014

city: Cardiff

first: Peter

last: Ghazal

address: Sir Geraint Evans Building, Academic Avenue

department: Systems Immunity University Research Institute

country: United Kingdom

institute: Cardiff University

description: Validation Test Set

hyb_protocol: Standard Affymetrix hybridisation and wash procedure EukGE-WS2v5.

scan_protocol: GeneChips were scanned using the Affymetrx GeneChip Scanner 3000 HR using the GCOS software tool

data_processing: R/Bioconductor using RMA normalisation, filtered for single present or marginal calls and empirical Bayes statistical test with Benjamini-Hochberg FDR adjustment performed for analysis of differential gene expression.

source_name: peripheral blood

label_protocol: Biotinylated cRNA were prepared with the standard Affymetrix GeneChip IVT labeling kit.

extract_protocol: RNA was extracted from whole blood samples with PAXgene blood RNA reagent, followed by clean-up and DNase I treatment with QIAGEN PAXgene blood RNA kit in accordance with the prescribed protocol provided with the kit. Quality control was performed with Agilent Bioanalyser.

value: peripheral blood

tag: corrected gestational age (weeks+days)

tag: gender

value: Male

tag: on antibiotics at time of sample

value: No

tag: bloodculture result

value: negative

tag: other positive results

value: no

tag: birthweight (g)


title: Inf012

description: Validation Test Set

value: Female

value: CSF:enterovirus on PCR.  CSF also grew coag neg staph, CSF WCC 300, RBC 9


title: Con030

description: Validation Test Set

value: umbilical swab grew proteus (may represent colonisation)


title: Inf032

description: Validation Test Set

value: yes CSF grew Listeria monocytogenes, CSF white cell count 551, RBC 119, urine no growth


title: pht1_3

description:
Δpht1 mutant strain haploid cells
Sample 10


title: Con014

description: Validation Test Set


title: Control Patient 4 Timepoint1

status: Public on Apr 01 2014

city: Singapore

first: Ahmad Nazri

last: Mohamed Naim

address: 60 Biopolis Street, Genome, #02-01

department: Infectious disease

country: Singapore

institute: Genome institute of Singapore

description:
Sample name: EDEN_FLU_829_2010
Patient 4 Timepoint1

hyb_protocol: Standard Illumina hybridization protocol

scan_protocol: Standard Illumina scanning protocol

data_processing: The data were analysed in Genespring GX11.5 software. Measurements less than 0.01 was set to 0.01. Data was then normalised at the 80th percentile.

source_name: Human whole blood

label_protocol: Biotinylated cRNA were prepared with the Illumina TotalPrep -96 RNA Amplification Kit for Illumina arrays

extract_protocol: Total RNA was extracted from whole blood drawn in pax-gene vacutainer tubes by PAX-gene RNA kit (Qiagen). Quality control was performed with NanoDrop 1000 instrument

tag: disease state

tag: sample type

tag: collection time

value: Less than 72 hour after symptoms


title: Control Patient 6 Timepoint3

description:
Sample name: EDEN_FLU_837_2010
Patient 6 Timepoint3

value: 2 to 5 weeks after symptoms


title: Control Patient 3 Timepoint2

description:
Sample name: EDEN_FLU_827_2010
Patient 3 Timepoint2

value: 3 to 7 dys after symptoms


title: Control Patient 7 Timepoint2

description:
Sample name: EDEN_FLU_839_2010
Patient 7 Timepoint2


title: Control Patient 8 Timepoint1

description:
Sample name: EDEN_FLU_841_2010
Patient 8 Timepoint1


title: Control Patient 2 Timepoint1

description:
Sample name: EDEN_FLU_820_2010
Patient 2 Timepoint1


title: Control Patient 5 Timepoint1

description:
Sample name: EDEN_FLU_832_2010
Patient 5 Timepoint1


title: Control Patient 6 Timepoint2

description:
Sample name: EDEN_FLU_836_2010
Patient 6 Timepoint2


title: Control Patient 7 Timepoint3

description:
Sample name: EDEN_FLU_840_2010
Patient 7 Timepoint3


title: Control Patient 3 Timepoint3

description:
Sample name: EDEN_FLU_828_2010
Patient 3 Timepoint3


title: Control Patient 6 Timepoint1

description:
Sample name: EDEN_FLU_835_2010
Patient 6 Timepoint1


title: Control Patient 2 Timepoint2

description:
Sample name: EDEN_FLU_821_2010
Patient 2 Timepoint2


title: Control Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_815_2010
Patient 1 Timepoint2


title: Control Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_814_2010
Patient 1 Timepoint1


title: Control Patient 7 Timepoint1

description:
Sample name: EDEN_FLU_838_2010
Patient 7 Timepoint1


title: Control Patient 5 Timepoint3

description:
Sample name: EDEN_FLU_834_2010
Patient 5 Timepoint3


title: SO H1N1 Patient 42 Timepoint3

description:
Sample name: EDEN_FLU_1310_2010
Patient 42 Timepoint3

value: SO H1N1


title: Control Patient 5 Timepoint2

description:
Sample name: EDEN_FLU_833_2010
Patient 5 Timepoint2

value: whole blood


title: SO H1N1 Patient 43 Timepoint1

description:
Sample name: EDEN_FLU_1311_2010
Patient 43 Timepoint1


title: Control Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_816_2010
Patient 1 Timepoint3


title: Control Patient 4 Timepoint3

description:
Sample name: EDEN_FLU_831_2010
Patient 4 Timepoint3


title: Control Patient 2 Timepoint3

description:
Sample name: EDEN_FLU_822_2010
Patient 2 Timepoint3


title: SO H1N1 Patient 43 Timepoint3

description:
Sample name: EDEN_FLU_1313_2010
Patient 43 Timepoint3


title: Control Patient 3 Timepoint1

description:
Sample name: EDEN_FLU_826_2010
Patient 3 Timepoint1


title: SO H1N1 Patient 42 Timepoint2

description:
Sample name: EDEN_FLU_1309_2010
Patient 42 Timepoint2


title: SO H1N1 Patient 42 Timepoint1

description:
Sample name: EDEN_FLU_1308_2010
Patient 42 Timepoint1


title: Control Patient 4 Timepoint2

description:
Sample name: EDEN_FLU_830_2010
Patient 4 Timepoint2


title: SO H1N1 Patient 43 Timepoint2

description:
Sample name: EDEN_FLU_1312_2010
Patient 43 Timepoint2


title: 11-0014

description: gcRMA normalized

extract_protocol: See original GSEs for clinical and technical information.

value: Control


title: SO H1N1 Patient 39 Timepoint1

description:
Sample name: EDEN_FLU_1299_2010
Patient 39 Timepoint1


title: SO H1N1 Patient 40 Timepoint2

description:
Sample name: EDEN_FLU_1303_2010
Patient 40 Timepoint2


title: SO H1N1 Patient 38 Timepoint2

description:
Sample name: EDEN_FLU_1297_2010
Patient 38 Timepoint2


title: SO H1N1 Patient 41 Timepoint2

description:
Sample name: EDEN_FLU_1306_2010
Patient 41 Timepoint2


title: SO H1N1 Patient 40 Timepoint1

description:
Sample name: EDEN_FLU_1302_2010
Patient 40 Timepoint1


title: SO H1N1 Patient 39 Timepoint2

description:
Sample name: EDEN_FLU_1300_2010
Patient 39 Timepoint2


title: SO H1N1 Patient 40 Timepoint3

description:
Sample name: EDEN_FLU_1304_2010
Patient 40 Timepoint3


title: SO H1N1 Patient 39 Timepoint3

description:
Sample name: EDEN_FLU_1301_2010
Patient 39 Timepoint3


title: SO H1N1 Patient 41 Timepoint3

description:
Sample name: EDEN_FLU_1307_2010
Patient 41 Timepoint3


title: SO H1N1 Patient 41 Timepoint1

description:
Sample name: EDEN_FLU_1305_2010
Patient 41 Timepoint1


title: SO H1N1 Patient 38 Timepoint3

description:
Sample name: EDEN_FLU_1298_2010
Patient 38 Timepoint3


title: SO H1N1 Patient 37 Timepoint3

description:
Sample name: EDEN_FLU_1295_2010
Patient 37 Timepoint3


title: SO H1N1 Patient 38 Timepoint1

description:
Sample name: EDEN_FLU_1296_2010
Patient 38 Timepoint1


title: SO H1N1 Patient 36 Timepoint2

description:
Sample name: EDEN_FLU_1291_2010
Patient 36 Timepoint2


title: SO H1N1 Patient 35 Timepoint3

description:
Sample name: EDEN_FLU_1289_2010
Patient 35 Timepoint3


title: SO H1N1 Patient 36 Timepoint1

description:
Sample name: EDEN_FLU_1290_2010
Patient 36 Timepoint1


title: SO H1N1 Patient 34 Timepoint3

description:
Sample name: EDEN_FLU_1286_2010
Patient 34 Timepoint3


title: SO H1N1 Patient 36 Timepoint3

description:
Sample name: EDEN_FLU_1292_2010
Patient 36 Timepoint3


title: SO H1N1 Patient 37 Timepoint1

description:
Sample name: EDEN_FLU_1293_2010
Patient 37 Timepoint1


title: SO H1N1 Patient 33 Timepoint3

description:
Sample name: EDEN_FLU_1283_2010
Patient 33 Timepoint3


title: 11-0018

description: gcRMA normalized

treatment_protocol: See original GSEs for clinical and technical information.


title: SO H1N1 Patient 34 Timepoint2

description:
Sample name: EDEN_FLU_1285_2010
Patient 34 Timepoint2


title: SO H1N1 Patient 33 Timepoint1

description:
Sample name: EDEN_FLU_1281_2010
Patient 33 Timepoint1


title: SO H1N1 Patient 35 Timepoint1

description:
Sample name: EDEN_FLU_1287_2010
Patient 35 Timepoint1


title: SO H1N1 Patient 31 Timepoint3

description:
Sample name: EDEN_FLU_1277_2010
Patient 31 Timepoint3


title: SO H1N1 Patient 34 Timepoint1

description:
Sample name: EDEN_FLU_1284_2010
Patient 34 Timepoint1


title: SO H1N1 Patient 37 Timepoint2

description:
Sample name: EDEN_FLU_1294_2010
Patient 37 Timepoint2


title: SO H1N1 Patient 32 Timepoint2

description:
Sample name: EDEN_FLU_1279_2010
Patient 32 Timepoint2


title: SO H1N1 Patient 35 Timepoint2

description:
Sample name: EDEN_FLU_1288_2010
Patient 35 Timepoint2


title: SO H1N1 Patient 32 Timepoint3

description:
Sample name: EDEN_FLU_1280_2010
Patient 32 Timepoint3


title: SO H1N1 Patient 33 Timepoint2

description:
Sample name: EDEN_FLU_1282_2010
Patient 33 Timepoint2


title: SO H1N1 Patient 30 Timepoint3

description:
Sample name: EDEN_FLU_1274_2010
Patient 30 Timepoint3


title: SO H1N1 Patient 29 Timepoint3

description:
Sample name: EDEN_FLU_1271_2010
Patient 29 Timepoint3


title: SO H1N1 Patient 29 Timepoint2

description:
Sample name: EDEN_FLU_1270_2010
Patient 29 Timepoint2


title: SO H1N1 Patient 30 Timepoint2

description:
Sample name: EDEN_FLU_1273_2010
Patient 30 Timepoint2


title: SO H1N1 Patient 31 Timepoint1

description:
Sample name: EDEN_FLU_1275_2010
Patient 31 Timepoint1


title: SO H1N1 Patient 32 Timepoint1

description:
Sample name: EDEN_FLU_1278_2010
Patient 32 Timepoint1


title: SO H1N1 Patient 29 Timepoint1

description:
Sample name: EDEN_FLU_1269_2010
Patient 29 Timepoint1


title: SO H1N1 Patient 30 Timepoint1

description:
Sample name: EDEN_FLU_1272_2010
Patient 30 Timepoint1


title: SO H1N1 Patient 31 Timepoint2

description:
Sample name: EDEN_FLU_1276_2010
Patient 31 Timepoint2


title: SO H1N1 Patient 27 Timepoint2

description:
Sample name: EDEN_FLU_1264_2010
Patient 27 Timepoint2


title: H3N2 Patient 18 Timepoint2

description:
Sample name: EDEN_FLU_1261_2010
Patient 18 Timepoint2


title: SO H1N1 Patient 27 Timepoint1

description:
Sample name: EDEN_FLU_1263_2010
Patient 27 Timepoint1


title: H1N1 Patient 9 Timepoint1

description:
Sample name: EDEN_FLU_1257_2010
Patient 9 Timepoint1


title: H1N1 Patient 9 Timepoint3

description:
Sample name: EDEN_FLU_1259_2010
Patient 9 Timepoint3


title: SO H1N1 Patient 28 Timepoint1

description:
Sample name: EDEN_FLU_1266_2010
Patient 28 Timepoint1


title: H3N2 Patient 18 Timepoint3

description:
Sample name: EDEN_FLU_1262_2010
Patient 18 Timepoint3


title: H3N2 Patient 18 Timepoint1

description:
Sample name: EDEN_FLU_1260_2010
Patient 18 Timepoint1


title: H3N2 Patient 16 Timepoint3

description:
Sample name: EDEN_FLU_1253_2010
Patient 16 Timepoint3


title: SO H1N1 Patient 28 Timepoint2

description:
Sample name: EDEN_FLU_1267_2010
Patient 28 Timepoint2


title: SO H1N1 Patient 28 Timepoint3

description:
Sample name: EDEN_FLU_1268_2010
Patient 28 Timepoint3


title: H1N1 Patient 9 Timepoint2

description:
Sample name: EDEN_FLU_1258_2010
Patient 9 Timepoint2


title: SO H1N1 Patient 27 Timepoint3

description:
Sample name: EDEN_FLU_1265_2010
Patient 27 Timepoint3


title: H3N2 Patient 17 Timepoint3

description:
Sample name: EDEN_FLU_1256_2010
Patient 17 Timepoint3


title: H3N2 Patient 16 Timepoint2

description:
Sample name: EDEN_FLU_1252_2010
Patient 16 Timepoint2


title: H3N2 Patient 17 Timepoint1

description:
Sample name: EDEN_FLU_1254_2010
Patient 17 Timepoint1


title: H3N2 Patient 15 Timepoint3

description:
Sample name: EDEN_FLU_1250_2010
Patient 15 Timepoint3


title: H3N2 Patient 17 Timepoint2

description:
Sample name: EDEN_FLU_1255_2010
Patient 17 Timepoint2


title: H3N2 Patient 15 Timepoint2

description:
Sample name: EDEN_FLU_1249_2010
Patient 15 Timepoint2


title: SO H1N1 Patient 26 Timepoint3

description:
Sample name: EDEN_FLU_1244_2010
Patient 26 Timepoint3


title: H3N2 Patient 16 Timepoint1

description:
Sample name: EDEN_FLU_1251_2010
Patient 16 Timepoint1


title: SO H1N1 Patient 25 Timepoint2

description:
Sample name: EDEN_FLU_1237_2010
Patient 25 Timepoint2


title: H3N2 Patient 15 Timepoint1

description:
Sample name: EDEN_FLU_1248_2010
Patient 15 Timepoint1


title: SO H1N1 Patient 25 Timepoint3

description:
Sample name: EDEN_FLU_1238_2010
Patient 25 Timepoint3


title: SO H1N1 Patient 26 Timepoint2

description:
Sample name: EDEN_FLU_1243_2010
Patient 26 Timepoint2


title: SO H1N1 Patient 25 Timepoint1

description:
Sample name: EDEN_FLU_1236_2010
Patient 25 Timepoint1


title: SO H1N1 Patient 23 Timepoint1

description:
Sample name: EDEN_FLU_1230_2010
Patient 23 Timepoint1


title: SO H1N1 Patient 24 Timepoint2

description:
Sample name: EDEN_FLU_1234_2010
Patient 24 Timepoint2


title: SO H1N1 Patient 24 Timepoint1

description:
Sample name: EDEN_FLU_1233_2010
Patient 24 Timepoint1


title: SO H1N1 Patient 22 Timepoint2

description:
Sample name: EDEN_FLU_1228_2010
Patient 22 Timepoint2


title: SO H1N1 Patient 22 Timepoint3

description:
Sample name: EDEN_FLU_1229_2010
Patient 22 Timepoint3


title: SO H1N1 Patient 23 Timepoint3

description:
Sample name: EDEN_FLU_1232_2010
Patient 23 Timepoint3


title: SO H1N1 Patient 24 Timepoint3

description:
Sample name: EDEN_FLU_1235_2010
Patient 24 Timepoint3


title: H1N1 Patient 8 Timepoint2

description:
Sample name: EDEN_FLU_1222_2010
Patient 8 Timepoint2


title: SO H1N1 Patient 23 Timepoint2

description:
Sample name: EDEN_FLU_1231_2010
Patient 23 Timepoint2


title: SO H1N1 Patient 22 Timepoint1

description:
Sample name: EDEN_FLU_1227_2010
Patient 22 Timepoint1


title: H3N2 Patient 13 Timepoint3

description:
Sample name: EDEN_FLU_1220_2010
Patient 13 Timepoint3


title: H3N2 Patient 14 Timepoint1

description:
Sample name: EDEN_FLU_1224_2010
Patient 14 Timepoint1


title: H3N2 Patient 14 Timepoint3

description:
Sample name: EDEN_FLU_1226_2010
Patient 14 Timepoint3


title: H3N2 Patient 13 Timepoint1

description:
Sample name: EDEN_FLU_1218_2010
Patient 13 Timepoint1


title: H1N1 Patient 8 Timepoint1

description:
Sample name: EDEN_FLU_1221_2010
Patient 8 Timepoint1


title: H1N1 Patient 6 Timepoint3

description:
Sample name: EDEN_FLU_1214_2010
Patient 6 Timepoint3


title: H3N2 Patient 14 Timepoint2

description:
Sample name: EDEN_FLU_1225_2010
Patient 14 Timepoint2


title: H1N1 Patient 7 Timepoint2

description:
Sample name: EDEN_FLU_1216_2010
Patient 7 Timepoint2


title: H3N2 Patient 13 Timepoint2

description:
Sample name: EDEN_FLU_1219_2010
Patient 13 Timepoint2


title: H1N1 Patient 7 Timepoint1

description:
Sample name: EDEN_FLU_1215_2010
Patient 7 Timepoint1


title: H1N1 Patient 7 Timepoint3

description:
Sample name: EDEN_FLU_1217_2010
Patient 7 Timepoint3


title: H1N1 Patient 6 Timepoint2

description:
Sample name: EDEN_FLU_1213_2010
Patient 6 Timepoint2


title: H1N1 Patient 4 Timepoint2

description:
Sample name: EDEN_FLU_1207_2010
Patient 4 Timepoint2


title: H1N1 Patient 6 Timepoint1

description:
Sample name: EDEN_FLU_1212_2010
Patient 6 Timepoint1


title: H1N1 Patient 5 Timepoint3

description:
Sample name: EDEN_FLU_1211_2010
Patient 5 Timepoint3


title: H1N1 Patient 4 Timepoint1

description:
Sample name: EDEN_FLU_1206_2010
Patient 4 Timepoint1


title: H1N1 Patient 5 Timepoint2

description:
Sample name: EDEN_FLU_1210_2010
Patient 5 Timepoint2


title: H1N1 Patient 5 Timepoint1

description:
Sample name: EDEN_FLU_1209_2010
Patient 5 Timepoint1


title: H1N1 Patient 3 Timepoint2

description:
Sample name: EDEN_FLU_1204_2010
Patient 3 Timepoint2


title: H1N1 Patient 3 Timepoint3

description:
Sample name: EDEN_FLU_1205_2010
Patient 3 Timepoint3


title: H1N1 Patient 2 Timepoint2

description:
Sample name: EDEN_FLU_1201_2010
Patient 2 Timepoint2


title: H1N1 Patient 2 Timepoint3

description:
Sample name: EDEN_FLU_1202_2010
Patient 2 Timepoint3


title: H1N1 Patient 3 Timepoint1

description:
Sample name: EDEN_FLU_1203_2010
Patient 3 Timepoint1


title: H3N2 Patient 12 Timepoint1

description:
Sample name: EDEN_FLU_1194_2010
Patient 12 Timepoint1


title: H1N1 Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_1199_2010
Patient 1 Timepoint3


title: H3N2 Patient 11 Timepoint3

description:
Sample name: EDEN_FLU_1190_2010
Patient 11 Timepoint3


title: H3N2 Patient 11 Timepoint1

description:
Sample name: EDEN_FLU_1188_2010
Patient 11 Timepoint1


title: H1N1 Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_1198_2010
Patient 1 Timepoint2


title: H1N1 Patient 4 Timepoint3

description:
Sample name: EDEN_FLU_1208_2010
Patient 4 Timepoint3


title: H1N1 Patient 2 Timepoint1

description:
Sample name: EDEN_FLU_1200_2010
Patient 2 Timepoint1


title: H1N1 Patient 8 Timepoint3

description:
Sample name: EDEN_FLU_1223_2010
Patient 8 Timepoint3


title: H3N2 Patient 12 Timepoint3

description:
Sample name: EDEN_FLU_1196_2010
Patient 12 Timepoint3


title: SO H1N1 Patient 26 Timepoint1

description:
Sample name: EDEN_FLU_1242_2010
Patient 26 Timepoint1


title: H3N2 Patient 9 Timepoint3

description:
Sample name: EDEN_FLU_1184_2010
Patient 9 Timepoint3


title: H3N2 Patient 9 Timepoint2

description:
Sample name: EDEN_FLU_1183_2010
Patient 9 Timepoint2


title: H3N2 Patient 10 Timepoint1

description:
Sample name: EDEN_FLU_1185_2010
Patient 10 Timepoint1


title: H1N1 Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_1197_2010
Patient 1 Timepoint1


title: H3N2 Patient 10 Timepoint3

description:
Sample name: EDEN_FLU_1187_2010
Patient 10 Timepoint3


title: H3N2 Patient 9 Timepoint1

description:
Sample name: EDEN_FLU_1182_2010
Patient 9 Timepoint1


title: H3N2 Patient 10 Timepoint2

description:
Sample name: EDEN_FLU_1186_2010
Patient 10 Timepoint2


title: H3N2 Patient 11 Timepoint2

description:
Sample name: EDEN_FLU_1189_2010
Patient 11 Timepoint2


title: H3N2 Patient 8 Timepoint3

description:
Sample name: EDEN_FLU_1181_2010
Patient 8 Timepoint3


title: H3N2 Patient 6 Timepoint3

description:
Sample name: EDEN_FLU_1175_2010
Patient 6 Timepoint3


title: H3N2 Patient 7 Timepoint2

description:
Sample name: EDEN_FLU_1177_2010
Patient 7 Timepoint2


title: H3N2 Patient 8 Timepoint1

description:
Sample name: EDEN_FLU_1179_2010
Patient 8 Timepoint1


title: H3N2 Patient 7 Timepoint3

description:
Sample name: EDEN_FLU_1178_2010
Patient 7 Timepoint3


title: H3N2 Patient 6 Timepoint2

description:
Sample name: EDEN_FLU_1174_2010
Patient 6 Timepoint2


title: H3N2 Patient 6 Timepoint1

description:
Sample name: EDEN_FLU_1173_2010
Patient 6 Timepoint1


title: H3N2 Patient 4 Timepoint3

description:
Sample name: EDEN_FLU_1169_2010
Patient 4 Timepoint3


title: H3N2 Patient 5 Timepoint2

description:
Sample name: EDEN_FLU_1171_2010
Patient 5 Timepoint2


title: H3N2 Patient 7 Timepoint1

description:
Sample name: EDEN_FLU_1176_2010
Patient 7 Timepoint1


title: H3N2 Patient 5 Timepoint1

description:
Sample name: EDEN_FLU_1170_2010
Patient 5 Timepoint1


title: H3N2 Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_1156_2010
Patient 1 Timepoint2


title: H3N2 Patient 12 Timepoint2

description:
Sample name: EDEN_FLU_1195_2010
Patient 12 Timepoint2


title: H3N2 Patient 4 Timepoint2

description:
Sample name: EDEN_FLU_1168_2010
Patient 4 Timepoint2


title: H3N2 Patient 3 Timepoint2

description:
Sample name: EDEN_FLU_1165_2010
Patient 3 Timepoint2


title: SO H1N1 Patient 21 Timepoint3

description:
Sample name: EDEN_FLU_1145_2010
Patient 21 Timepoint3


title: H3N2 Patient 8 Timepoint2

description:
Sample name: EDEN_FLU_1180_2010
Patient 8 Timepoint2


title: H3N2 Patient 3 Timepoint3

description:
Sample name: EDEN_FLU_1166_2010
Patient 3 Timepoint3


title: H3N2 Patient 3 Timepoint1

description:
Sample name: EDEN_FLU_1164_2010
Patient 3 Timepoint1


title: H3N2 Patient 2 Timepoint3

description:
Sample name: EDEN_FLU_1160_2010
Patient 2 Timepoint3


title: H3N2 Patient 5 Timepoint3

description:
Sample name: EDEN_FLU_1172_2010
Patient 5 Timepoint3


title: H3N2 Patient 4 Timepoint1

description:
Sample name: EDEN_FLU_1167_2010
Patient 4 Timepoint1


title: SO H1N1 Patient 20 Timepoint3

description:
Sample name: EDEN_FLU_1142_2010
Patient 20 Timepoint3


title: H3N2 Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_1157_2010
Patient 1 Timepoint3


title: H3N2 Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_1155_2010
Patient 1 Timepoint1


title: Rhino Patient 9 Timepoint2

description:
Sample name: EDEN_FLU_1138_2010
Patient 9 Timepoint2

value: Rhino


title: Rhino Patient 9 Timepoint3

description:
Sample name: EDEN_FLU_1139_2010
Patient 9 Timepoint3


title: H3N2 Patient 2 Timepoint2

description:
Sample name: EDEN_FLU_1159_2010
Patient 2 Timepoint2


title: H3N2 Patient 2 Timepoint1

description:
Sample name: EDEN_FLU_1158_2010
Patient 2 Timepoint1


title: SO H1N1 Patient 21 Timepoint1

description:
Sample name: EDEN_FLU_1143_2010
Patient 21 Timepoint1


title: SO H1N1 Patient 20 Timepoint1

description:
Sample name: EDEN_FLU_1140_2010
Patient 20 Timepoint1


title: SO H1N1 Patient 21 Timepoint2

description:
Sample name: EDEN_FLU_1144_2010
Patient 21 Timepoint2


title: SO H1N1 Patient 20 Timepoint2

description:
Sample name: EDEN_FLU_1141_2010
Patient 20 Timepoint2


title: Rhino Patient 8 Timepoint3

description:
Sample name: EDEN_FLU_1130_2010
Patient 8 Timepoint3


title: Rhino Patient 8 Timepoint2

description:
Sample name: EDEN_FLU_1129_2010
Patient 8 Timepoint2


title: Rhino Patient 9 Timepoint1

description:
Sample name: EDEN_FLU_1137_2010
Patient 9 Timepoint1


title: SO H1N1 Patient 17 Timepoint1

description:
Sample name: EDEN_FLU_1092_2010
Patient 17 Timepoint1


title: Rhino Patient 7 Timepoint3

description:
Sample name: EDEN_FLU_1097_2010
Patient 7 Timepoint3


title: SO H1N1 Patient 17 Timepoint2

description:
Sample name: EDEN_FLU_1093_2010
Patient 17 Timepoint2


title: SO H1N1 Patient 18 Timepoint1

description:
Sample name: EDEN_FLU_1110_2010
Patient 18 Timepoint1


title: SO H1N1 Patient 18 Timepoint3

description:
Sample name: EDEN_FLU_1112_2010
Patient 18 Timepoint3


title: SO H1N1 Patient / Rhino Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_1102_2010
Patient / Rhino Patient 1 Timepoint2


title: SO H1N1 Patient 19 Timepoint2

description:
Sample name: EDEN_FLU_1120_2010
Patient 19 Timepoint2


title: Rhino Patient 8 Timepoint1

description:
Sample name: EDEN_FLU_1128_2010
Patient 8 Timepoint1


title: SO H1N1 Patient 17 Timepoint3

description:
Sample name: EDEN_FLU_1094_2010
Patient 17 Timepoint3


title: Rhino Patient 6 Timepoint2

description:
Sample name: EDEN_FLU_1078_2010
Patient 6 Timepoint2


title: SO H1N1 Patient 19 Timepoint3

description:
Sample name: EDEN_FLU_1121_2010
Patient 19 Timepoint3


title: SO H1N1 Patient 19 Timepoint1

description:
Sample name: EDEN_FLU_1119_2010
Patient 19 Timepoint1


title: Rhino Patient 7 Timepoint2

description:
Sample name: EDEN_FLU_1096_2010
Patient 7 Timepoint2


title: SO H1N1 Patient / Rhino Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_1103_2010
Patient / Rhino Patient 1 Timepoint3


title: SO H1N1 Patient 18 Timepoint2

description:
Sample name: EDEN_FLU_1111_2010
Patient 18 Timepoint2


title: SO H1N1 Patient 15 Timepoint2

description:
Sample name: EDEN_FLU_1012_2010
Patient 15 Timepoint2


title: SO H1N1 Patient 15 Timepoint1

description:
Sample name: EDEN_FLU_1011_2010
Patient 15 Timepoint1


title: SO H1N1 Patient 16 Timepoint2

description:
Sample name: EDEN_FLU_1027_2010
Patient 16 Timepoint2


title: SO H1N1 Patient 16 Timepoint3

description:
Sample name: EDEN_FLU_1028_2010
Patient 16 Timepoint3


title: SO H1N1 Patient 14 Timepoint3

description:
Sample name: EDEN_FLU_1001_2010
Patient 14 Timepoint3


title: Rhino Patient 7 Timepoint1

description:
Sample name: EDEN_FLU_1095_2010
Patient 7 Timepoint1


title: SO H1N1 Patient 16 Timepoint1

description:
Sample name: EDEN_FLU_1026_2010
Patient 16 Timepoint1


title: SO H1N1 Patient 14 Timepoint2

description:
Sample name: EDEN_FLU_1000_2010
Patient 14 Timepoint2


title: Rhino Patient 6 Timepoint3

description:
Sample name: EDEN_FLU_1079_2010
Patient 6 Timepoint3


title: Rhino Patient 6 Timepoint1

description:
Sample name: EDEN_FLU_1077_2010
Patient 6 Timepoint1


title: SO H1N1 Patient / Rhino Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_1101_2010
Patient / Rhino Patient 1 Timepoint1


title: SO H1N1 Patient 14 Timepoint1

description:
Sample name: EDEN_FLU_999_2010
Patient 14 Timepoint1


title: SO H1N1 Patient 13 Timepoint3

description:
Sample name: EDEN_FLU_995_2010
Patient 13 Timepoint3


title: SO H1N1 Patient 13 Timepoint2

description:
Sample name: EDEN_FLU_994_2010
Patient 13 Timepoint2


title: SO H1N1 Patient 13 Timepoint1

description:
Sample name: EDEN_FLU_993_2010
Patient 13 Timepoint1


title: SO H1N1 Patient 12 Timepoint3

description:
Sample name: EDEN_FLU_983_2010
Patient 12 Timepoint3


title: SO H1N1 Patient 10 Timepoint3

description:
Sample name: EDEN_FLU_959_2010
Patient 10 Timepoint3


title: SO H1N1 Patient 11 Timepoint2

description:
Sample name: EDEN_FLU_961_2010
Patient 11 Timepoint2


title: SO H1N1 Patient 12 Timepoint1

description:
Sample name: EDEN_FLU_981_2010
Patient 12 Timepoint1


title: SO H1N1 Patient 10 Timepoint1

description:
Sample name: EDEN_FLU_957_2010
Patient 10 Timepoint1


title: SO H1N1 Patient 12 Timepoint2

description:
Sample name: EDEN_FLU_982_2010
Patient 12 Timepoint2


title: SO H1N1 Patient 11 Timepoint3

description:
Sample name: EDEN_FLU_962_2010
Patient 11 Timepoint3


title: SO H1N1 Patient 11 Timepoint1

description:
Sample name: EDEN_FLU_960_2010
Patient 11 Timepoint1


title: SO H1N1 Patient 7 Timepoint2

description:
Sample name: EDEN_FLU_940_2010
Patient 7 Timepoint2


title: Rhino Patient 5 Timepoint3

description:
Sample name: EDEN_FLU_929_2010
Patient 5 Timepoint3


title: SO H1N1 Patient 8 Timepoint3

description:
Sample name: EDEN_FLU_944_2010
Patient 8 Timepoint3


title: SO H1N1 Patient 8 Timepoint1

description:
Sample name: EDEN_FLU_942_2010
Patient 8 Timepoint1


title: Rhino Patient 5 Timepoint1

description:
Sample name: EDEN_FLU_927_2010
Patient 5 Timepoint1


title: SO H1N1 Patient 9 Timepoint2

description:
Sample name: EDEN_FLU_946_2010
Patient 9 Timepoint2


title: SO H1N1 Patient 8 Timepoint2

description:
Sample name: EDEN_FLU_943_2010
Patient 8 Timepoint2


title: SO H1N1 Patient 9 Timepoint3

description:
Sample name: EDEN_FLU_947_2010
Patient 9 Timepoint3


title: SO H1N1 Patient 6 Timepoint1

description:
Sample name: EDEN_FLU_918_2010
Patient 6 Timepoint1


title: SO H1N1 Patient 7 Timepoint3

description:
Sample name: EDEN_FLU_941_2010
Patient 7 Timepoint3


title: SO H1N1 Patient 6 Timepoint2

description:
Sample name: EDEN_FLU_919_2010
Patient 6 Timepoint2


title: SO H1N1 Patient 10 Timepoint2

description:
Sample name: EDEN_FLU_958_2010
Patient 10 Timepoint2


title: SO H1N1 Patient 5 Timepoint3

description:
Sample name: EDEN_FLU_917_2010
Patient 5 Timepoint3


title: Rhino Patient 5 Timepoint2

description:
Sample name: EDEN_FLU_928_2010
Patient 5 Timepoint2


title: SO H1N1 Patient 5 Timepoint1

description:
Sample name: EDEN_FLU_915_2010
Patient 5 Timepoint1


title: SO H1N1 Patient 6 Timepoint3

description:
Sample name: EDEN_FLU_920_2010
Patient 6 Timepoint3


title: SO H1N1 Patient 15 Timepoint3

description:
Sample name: EDEN_FLU_1013_2010
Patient 15 Timepoint3


title: SO H1N1 Patient 5 Timepoint2

description:
Sample name: EDEN_FLU_916_2010
Patient 5 Timepoint2


title: SO H1N1 Patient 9 Timepoint1

description:
Sample name: EDEN_FLU_945_2010
Patient 9 Timepoint1


title: Rhino Patient 4 Timepoint3

description:
Sample name: EDEN_FLU_911_2010
Patient 4 Timepoint3


title: SO H1N1 Patient 4 Timepoint1

description:
Sample name: EDEN_FLU_906_2010
Patient 4 Timepoint1


title: Rhino Patient 4 Timepoint2

description:
Sample name: EDEN_FLU_910_2010
Patient 4 Timepoint2


title: SO H1N1 Patient 4 Timepoint3

description:
Sample name: EDEN_FLU_908_2010
Patient 4 Timepoint3


title: SO H1N1 Patient 4 Timepoint2

description:
Sample name: EDEN_FLU_907_2010
Patient 4 Timepoint2


title: SO H1N1 Patient 7 Timepoint1

description:
Sample name: EDEN_FLU_939_2010
Patient 7 Timepoint1


title: SO H1N1 Patient 2 Timepoint3

description:
Sample name: EDEN_FLU_896_2010
Patient 2 Timepoint3


title: SO H1N1 Patient 3 Timepoint2

description:
Sample name: EDEN_FLU_904_2010
Patient 3 Timepoint2


title: SO H1N1 Patient 2 Timepoint1

description:
Sample name: EDEN_FLU_894_2010
Patient 2 Timepoint1


title: SO H1N1 Patient 3 Timepoint3

description:
Sample name: EDEN_FLU_905_2010
Patient 3 Timepoint3


title: WT 2

status: Public on Mar 13 2014

city: London

first: Danny

middle: Asher

last: Bitton

address: Darwin Building, Gower Street

department: Department of Genetics, Evolution & Environment

institute: University College London

description: WT_2 (Name in expression table)

data_processing:
Paired-end reads of length 51 bases (each part) originating from each sample were aligned using Bowtie 0.12.7 to the S. pombe genome sequence (Ensembl S. pombe, Build EF1) as well as to its corresponding exon-exon junctions database (only thesecond part of the paired-end reads was considered). Up to 3 mismatches were allowed. Reads that matched multiple loci were removed from further analysis and the resultant alignment files were processed to generate ‘pile-ups’ against each chromosome.
Searches were performed against the genome sequence combined with a dataset of known exon-exon junctions as defined by Ensembl S. pombe release-13. To ensure that a 51-base read mapped to a splice junction, only the last 45 bases of the first exon and the first 45 bases of the second exon were considered (if the exon length exceeded 45 nucleotides). In this way, reads that overlapped a junction by less than 6 nucleotides were excluded. Reads that matched to more than one junction or elsewhere in the genome were also discarded.
Genome_build: Ensembl S. pombe, Build EF1, version 58.1a
Supplementary_files_format_and_content: Expression table and RPKM summary for all samples tab-delimited

molecule: polyA RNA

source_name: S. pombe cells

growth_protocol: Two biological replicates of the WT, Y1F, S2A, T4A, S7A,Y1F-S7A, S2A-S7A and T4A-S7A cultures were grown in YES (yeast extracts plus supplements) media at 30°C till they reached OD600 0.4 -0.7.

extract_protocol:
Cells were harvested and RNA was isolated using the Qiagen RNeasy kit. RNA quality was assessed on a Bioanalyzer instrument (Agilent) and 1µg of total RNA was used to prepare polyA+ RNA using the Illumina TruSeq RNA sample kit .
RNA-seq libraries were prepared from polyA+ RNA using the Illumina TruSeq stranded total RNA Sample Prep Kit according to the manufacturers protocol. Indexed libraries were normalized and pooled (8 samples per lane) for paired-end sequencing performed using an Illumina HiSeq 2000 instrument at the Weill Cornell Medical College Genome Core Facility (in New York).

tag: strain

value: rpb1CTD-WT 1-18

tag: genetic markers

value: h- ade6 ura4-D18 leu1–32


title: SO H1N1 Patient 3 Timepoint1

description:
Sample name: EDEN_FLU_903_2010
Patient 3 Timepoint1


title: WT 1

description: WT_ 1 (Name in expression table)


title: Rhino Patient 3 Timepoint3

description:
Sample name: EDEN_FLU_878_2010
Patient 3 Timepoint3


title: Rhino Patient 3 Timepoint1

description:
Sample name: EDEN_FLU_876_2010
Patient 3 Timepoint1


title: Rhino Patient 3 Timepoint2

description:
Sample name: EDEN_FLU_877_2010
Patient 3 Timepoint2


title: SO H1N1 Patient 2 Timepoint2

description:
Sample name: EDEN_FLU_895_2010
Patient 2 Timepoint2


title: Rhino Patient 2 Timepoint3

description:
Sample name: EDEN_FLU_825_2010
Patient 2 Timepoint3


title: SO H1N1 Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_1022_2010
Patient 1 Timepoint3


title: Rhino Patient 2 Timepoint2

description:
Sample name: EDEN_FLU_824_2010
Patient 2 Timepoint2


title: Rhino Patient 2 Timepoint1

description:
Sample name: EDEN_FLU_823_2010
Patient 2 Timepoint1


title: Rhino Patient 1 Timepoint3

description:
Sample name: EDEN_FLU_813_2010
Patient 1 Timepoint3


title: Rhino Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_812_2010
Patient 1 Timepoint2


title: Rhino Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_811_2010
Patient 1 Timepoint1


title: TB 7 6m

status: Public on Feb 15 2014

city: Shenzhen

first: Xinchun

last: Chen

address: No.29, Bulan Road

country: China

institute: Shenzhen Third People's Hospital

description: Gene expression data from PBMC

hyb_protocol: Following fragmentation, 12.5 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.

scan_protocol: GeneChips were scanned using the GeneChip Scanner 7G

data_processing: The data value(log2) were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.

source_name: PBMC from TB

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 250 ng total RNA .

growth_protocol: Peripheral whole blood was collected in heparinized vacutainer tubes (Becton Dickinson) and subjected to PBMC isolation within 4 hours.

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: PBMC was isolated from peripheral whole blood using Ficoll-Plaque Plus (Amersham Biosciences, USA) according to the manufacturer’s protocol. In brief, one ratio of diluted blood (1:1 ratio in PBS) sample was layered on 2 ratio of Ficoll-Plaque Plus (Amersham Biosciences, USA), pelleted (400g, 30 minutes at 18-20°C) and the buffy coat was collected, washed twice with PBS. PBMC with viability higher than 90% was subjected to RNA extraction.

value: TB patient after anti-tuberculosis treatment for 6 months

value: PBMC


title: TB 8 6m

description: Gene expression data from PBMC


title: TB 5 6m

description: Gene expression data from PBMC


title: TB 4 3m

description: Gene expression data from PBMC

value: TB patient after anti-tuberculosis treatment for 3 months


title: SO H1N1 Patient 1 Timepoint1

description:
Sample name: EDEN_FLU_1020_2010
Patient 1 Timepoint1


title: TB 8 3m

description: Gene expression data from PBMC


title: TB 6 6m

description: Gene expression data from PBMC


title: SO H1N1 Patient 1 Timepoint2

description:
Sample name: EDEN_FLU_1021_2010
Patient 1 Timepoint2


title: TB 3 6m

description: Gene expression data from PBMC


title: TB 4 6m

description: Gene expression data from PBMC


title: TB 1 6m

description: Gene expression data from PBMC


title: HD 2

description: Gene expression data from PBMC

source_name: PBMC from HC

value: healthy donor


title: TB 9 6m

description: Gene expression data from PBMC


title: TB 2 3m

description: Gene expression data from PBMC


title: TB 3 3m

description: Gene expression data from PBMC


title: LTBI 5

description: Gene expression data from PBMC

source_name: PBMC from LTBI

value: latent tuberculosis infection


title: Rhino Patient 4 Timepoint1

description:
Sample name: EDEN_FLU_909_2010
Patient 4 Timepoint1


title: TB 2 6m

description: Gene expression data from PBMC


title: LTBI 1

description: Gene expression data from PBMC


title: LTBI 2

description: Gene expression data from PBMC


title: HD 1

description: Gene expression data from PBMC


title: HD 3

description: Gene expression data from PBMC


title: LTBI 3

description: Gene expression data from PBMC


title: HD 6

description: Gene expression data from PBMC


title: TB 7 3m

description: Gene expression data from PBMC


title: TB 9 3m

description: Gene expression data from PBMC


title: TB 6 3m

description: Gene expression data from PBMC


title: LTBI 4

description: Gene expression data from PBMC


title: HD 4

description: Gene expression data from PBMC


title: LTBI 6

description: Gene expression data from PBMC


title: TB 4

description: Gene expression data from PBMC

value: tuberculosis


title: TB 1 3m

description: Gene expression data from PBMC


title: TB 1

description: Gene expression data from PBMC


title: TB 6

description: Gene expression data from PBMC


title: HD 5

description: Gene expression data from PBMC


title: TB 5

description: Gene expression data from PBMC


title: TB 5 3m

description: Gene expression data from PBMC


title: TB 2

description: Gene expression data from PBMC


title: TB 7

description: Gene expression data from PBMC


title: TB 3

description: Gene expression data from PBMC


title: Kidney-mutant- rep3

status: Public on Jan 17 2014

city: Nashville

first: Navid

last: Farsijani

state: Tennesee

address: 1161 21st Avenue South

institute: Vanderbilt University

hyb_protocol: Following fragmentation, 10.5 ug of cRNA were hybridized on Mouse Gene 1.0 ST Array.

scan_protocol: GeneChips were scanned using Affymetrix GeneChip Command Console.

data_processing: Summarized probe set data were generated using LIMMA analysis.

organism: Mus musculus

source_name: Whole kidney, mutant

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol

extract_protocol: Total RNA was isolatied using TRIzol reagent (Invitrogen) and was purified using the RNeasy Kit (Qiagen).

treatment_protocol: Mice were treated with doxycycline containing drinking water at a concentration of 0.2 mg/ml in 5% sucrose water for two weeks

tag: genotype

value: kidney

value: female

tag: genetic background

value: mixed C57BL/6 - SV127


title: Kidney-control- rep1

source_name: Whole kidney, control

value: control


title: Kidney-control- rep4


title: Kidney-mutant- rep4


title: Kidney-control- rep2


title: Kidney-control- rep3


title: TB 8

description: Gene expression data from PBMC


title: Kidney-mutant- rep2


title: Kidney-mutant- rep1


title: MM 1

status: Public on Jan 01 2014

city: Copenhagen

first: Nicolas

last: Rapin

address: Ole Maaloes vej 5

department: Finsen Laboratory

country: Denmark

institute: Copenhagen University

description: Gene expression data from purified cell from the hematopoietic system

hyb_protocol: Affymetrix EukGE-WS2v4_450 Hybridization protocol

scan_protocol: arrays were scanned in the Affymetrix Genearray 2500 scanner to generate flourescent images, as described in Affymetrix GeneChip protocol.

data_processing: Cell intesity files (CEL files) were generated in the Genechip Command Console Software (AGCC), (Affymetrix, Santa Clara, CA, USA)

source_name: Metamyelocytes

label_protocol: 2.5ug amplified cDNA was fragmentated and labeled using Encore Biotin Module V2 according to manufactures instructions. www.nugeninc.com/nugen/index.cfm/products/pl/target-preparation/encore-biotin-module/

growth_protocol: Mononuclear bone marrow cells  from heathly donors were enriched for 34+ and hematopoietic stem and progenitor cells were sorted by FACS.

extract_protocol: RNeasy from Qiagen. According to manufaturer protocol.  Followed by amplification with NuGEN's WT Ovation Pico kit. Again according to manufacturer protocol.

tag: cell type

value: Metamyelocytes


title: BC 3

source_name: Band cells

value: Band cells


title: PMN 1

source_name: Polymorphonuclear cells

value: Polymorphonuclear cells


title: TB 9

description: Gene expression data from PBMC


title: GMP 5

source_name: Granulocyte Macrophage Progenitors

value: Granulocyte Macrophage Progenitors


title: PMN 3


title: MY 2

source_name: Myelocytes

value: Myelocytes


title: BC 2


title: MEP 1

source_name: Megakaryocyte-Erythroid Progenitors

value: Megakaryocyte-Erythroid Progenitors


title: BC 4


title: early_PM 2

source_name: Early Promyelocytes

value: Early Promyelocytes


title: MY 1


title: PMN 2


title: late_PM 1

source_name: Late Promyelocytes

value: Late Promyelocytes


title: GMP 4


title: MM 2


title: MEP 2


title: late_PM 2


title: GMP 3


title: late_PM 3


title: CMP 2

source_name: Common myeloid progenitors

value: Common myeloid progenitors


title: GMP 1


title: CMP 3


title: early_PM 1


title: BC 1


title: GMP 2


title: MPP 1

source_name: Multipotent Progenitors

value: Multipotent Progenitors


title: MPP 2


title: HSC 2

source_name: Hematopoietic Stem Cells

value: Hematopoietic Stem Cells


title: HSC 4


title: HSC 3


title: early_PM 3


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_021

status: Public on Nov 16 2013

city: Durham

first: Geoffrey

middle: S

last: Ginsburg

state: NC

address: 101 Science Dr, CIEMAS 2111, Box 3382

department: Genomic Medicine

institute: Duke University Medical Center

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

hyb_protocol: 20 ug of antisense cRNA was hybridized for 16+ hr at 45C on GeneChip Human U133A array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Midi_euk2v3_450 protocol

scan_protocol: GeneChips were scanned using the Affymetrix GeneArray Scanner 3000 7G.

data_processing: ExpressionStat 5.0

label: Biotin

source_name: RNA from peripheral human blood from adult participating in influenza challenge study

label_protocol: Biotinylated antisense strand cRNA was prepared according to the standard Affymetrix protocol from 2.5 ug total RNA utilizing peptide nucleic acids complimentary to globin mRNA to block amplification of those transcripts(GeneChipÂ® 1 cycle labeling kit with Globin Reduction protocol (Affymetrix) Data was Generated at Expression Analysis, Inc (Durham, NC))

extract_protocol: Total RNA extracted from PaxGene Blood tubes as per the manufacturer's protocol.

value: blood

tag: challenge virus

tag: clinical phenotype

value: Symptomatic

tag: total symptom score

tag: subject id

tag: time point

value: Pre-Challenge Baseline


title: HSC 1


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_023

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

tag: tissue

value: Asymptomatic


title: MM 3


title: Influenza challenge sample at 84 hours from subject H1N1_021

description:
Gene expression data at 84 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 84 hours


title: Influenza challenge sample at 69.5 hours from subject H1N1_022

description:
Gene expression data at 69.5 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 69.5 hours


title: Influenza challenge sample at 93.5 hours from subject H1N1_022

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 93.5 hours


title: Influenza challenge sample at 93.5 hours from subject H1N1_021

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_021

description:
Gene expression data at 101 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 101 hours


title: Influenza challenge sample at 101 hours from subject H1N1_023

description:
Gene expression data at 101 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_022

description:
Gene expression data at 101 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_024

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_021

description:
Gene expression data at 53 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 53 hours


title: Influenza challenge sample at 93.5 hours from subject H1N1_023

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_022

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_024

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_022

description:
Gene expression data at 53 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_024

description:
Gene expression data at 53 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_023

description:
Gene expression data at 53 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_024

description:
Gene expression data at 101 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 84 hours from subject H1N1_023

description:
Gene expression data at 84 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 84 hours from subject H1N1_024

description:
Gene expression data at 84 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_021

description:
Gene expression data at 108 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 108 hours


title: Influenza challenge sample at 108 hours from subject H1N1_023

description:
Gene expression data at 108 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_024

description:
Gene expression data at 108 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: CMP 1

description: Gene expression data from purified cell from the hematopoietic system


title: Influenza challenge sample at 108 hours from subject H1N1_022

description:
Gene expression data at 108 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_021

description:
Gene expression data at 60 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 60 hours


title: Influenza challenge sample at 77 hours from subject H1N1_021

description:
Gene expression data at 77 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 77 hours


title: Influenza challenge sample at 36 hours from subject H1N1_022

description:
Gene expression data at 36 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 36 hours


title: Influenza challenge sample at 77 hours from subject H1N1_024

description:
Gene expression data at 77 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_023

description:
Gene expression data at 77 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 36 hours from subject H1N1_023

description:
Gene expression data at 36 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_024

description:
Gene expression data at 60 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 36 hours from subject H1N1_021

description:
Gene expression data at 36 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_022

description:
Gene expression data at 77 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 36 hours from subject H1N1_024

description:
Gene expression data at 36 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_024

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 45.5 hours


title: Influenza challenge sample at 69.5 hours from subject H1N1_024

description:
Gene expression data at 69.5 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_023

description:
Gene expression data at 60 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_023

description:
Gene expression data at 12 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 12 hours


title: Influenza challenge sample at 21.5 hours from subject H1N1_023

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 21.5 hours


title: Influenza challenge sample at 84 hours from subject H1N1_022

description:
Gene expression data at 84 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_021

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_024

description:
Gene expression data at 12 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_023

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_022

description:
Gene expression data at 60 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_022

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_024

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_021

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_021

description:
Gene expression data at 12 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_022

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 5 hours from subject H1N1_023

description:
Gene expression data at 5 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 5 hours


title: Influenza challenge sample at 12 hours from subject H1N1_022

description:
Gene expression data at 12 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: blood


title: Influenza challenge sample at 5 hours from subject H1N1_021

description:
Gene expression data at 5 hours from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Symptomatic


title: Influenza challenge sample at 29 hours from subject H1N1_023

description:
Gene expression data at 29 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 29 hours


title: Influenza challenge sample at 5 hours from subject H1N1_022

description:
Gene expression data at 5 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Asymptomatic


title: Influenza challenge sample at 5 hours from subject H1N1_024

description:
Gene expression data at 5 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 69.5 hours from subject H1N1_023

description:
Gene expression data at 69.5 hours from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 29 hours from subject H1N1_022

description:
Gene expression data at 29 hours from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 29 hours from subject H1N1_024

description:
Gene expression data at 29 hours from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_019

description:
Gene expression data at 53 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_020

description:
Gene expression data at 53 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_019

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_018

description:
Gene expression data at 53 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Baseline from subject H1N1_021

description:
Gene expression data at Baseline from adult human volunteer H1N1_021 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Baseline


title: Influenza challenge sample at 84 hours from subject H1N1_020

description:
Gene expression data at 84 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 84 hours


title: Influenza challenge sample at Baseline from subject H1N1_024

description:
Gene expression data at Baseline from adult human volunteer H1N1_024 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 84 hours from subject H1N1_017

description:
Gene expression data at 84 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_017

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 93.5 hours


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_019

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Pre-Challenge Baseline


title: Influenza challenge sample at 84 hours from subject H1N1_018

description:
Gene expression data at 84 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Baseline from subject H1N1_023

description:
Gene expression data at Baseline from adult human volunteer H1N1_023 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 53 hours from subject H1N1_016

description:
Gene expression data at 53 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 53 hours


title: Influenza challenge sample at 53 hours from subject H1N1_017

description:
Gene expression data at 53 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_020

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_020

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_018

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 93.5 hours from subject H1N1_016

description:
Gene expression data at 93.5 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 5 hours from subject H1N1_017

description:
Gene expression data at 5 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_020

description:
Gene expression data at 108 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 108 hours


title: Influenza challenge sample at 101 hours from subject H1N1_018

description:
Gene expression data at 101 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 101 hours


title: Influenza challenge sample at 84 hours from subject H1N1_019

description:
Gene expression data at 84 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_020

description:
Gene expression data at 101 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_018

description:
Gene expression data at 108 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_017

description:
Gene expression data at 101 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 101 hours from subject H1N1_016

description:
Gene expression data at 101 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_017

description:
Gene expression data at 108 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_020

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_016

description:
Gene expression data at 77 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 77 hours


title: Influenza challenge sample at 60 hours from subject H1N1_019

description:
Gene expression data at 60 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 60 hours


title: Influenza challenge sample at 84 hours from subject H1N1_016

description:
Gene expression data at 84 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_017

description:
Gene expression data at 77 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_016

description:
Gene expression data at 108 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 108 hours from subject H1N1_019

description:
Gene expression data at 108 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 29 hours from subject H1N1_018

description:
Gene expression data at 29 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_018

description:
Gene expression data at 77 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 69.5 hours from subject H1N1_017

description:
Gene expression data at 69.5 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 69.5 hours


title: Influenza challenge sample at 60 hours from subject H1N1_020

description:
Gene expression data at 60 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_016

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_017

description:
Gene expression data at 60 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 60 hours from subject H1N1_018

description:
Gene expression data at 60 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_019

description:
Gene expression data at 77 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 77 hours from subject H1N1_020

description:
Gene expression data at 77 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_017

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_016

description:
Gene expression data at 12 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 12 hours


title: Influenza challenge sample at 60 hours from subject H1N1_016

description:
Gene expression data at 60 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_020

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 21.5 hours


title: Influenza challenge sample at Baseline from subject H1N1_022

description:
Gene expression data at Baseline from adult human volunteer H1N1_022 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 36 hours from subject H1N1_019

description:
Gene expression data at 36 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 36 hours


title: Influenza challenge sample at 21.5 hours from subject H1N1_019

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: blood


title: Influenza challenge sample at 36 hours from subject H1N1_020

description:
Gene expression data at 36 hours from adult human volunteer H1N1_020 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Symptomatic


title: Influenza challenge sample at 69.5 hours from subject H1N1_019

description:
Gene expression data at 69.5 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_018

description:
Gene expression data at 12 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 36 hours from subject H1N1_018

description:
Gene expression data at 36 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 45.5 hours from subject H1N1_017

description:
Gene expression data at 45.5 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 45.5 hours


title: Influenza challenge sample at 36 hours from subject H1N1_016

description:
Gene expression data at 36 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: Asymptomatic


title: Influenza challenge sample at 101 hours from subject H1N1_019

description:
Gene expression data at 101 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 21.5 hours from subject H1N1_018

description:
Gene expression data at 21.5 hours from adult human volunteer H1N1_018 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_019

description:
Gene expression data at 12 hours from adult human volunteer H1N1_019 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 12 hours from subject H1N1_017

description:
Gene expression data at 12 hours from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at Pre-Challenge Baseline from subject H1N1_017

description:
Gene expression data at Pre-Challenge Baseline from adult human volunteer H1N1_017 challenged with H1N1 virus who became symptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.


title: Influenza challenge sample at 29 hours from subject H1N1_016

description:
Gene expression data at 29 hours from adult human volunteer H1N1_016 challenged with H1N1 virus who remained asymptomatic.
Healthy adult volunteers were inoculated intranasally with either influenza H3N2 or influenza H1N1 virus.  Symptoms were recorded at standard intervals and a time course of peripheral blood was collected in RNA PaxGene tubes.

value: 29 hours